The reformulation of OxyContin to reduce opioid abuse has led to a hepatitis C epidemic. The reformulation of OxyContin to reduce opioid abuse has led to a hepatitis C disorder, according to a study: “One study warns that some drug control strategies can cause more harm to health. “ScienceDaily. According to the results of one study, the reformulation of OxyContin to stop opioid abuse led to a hepatitis C disorder: A study warns that some drug control strategies can cause other health problems. “Even with recent advances in the treatment of hepatitis C, the dramatic rise in infections is a major public health problem that can result in huge long-term costs if infected people are not identified and treated,” said Rosalie Liccardo Pacula, co-author and co-director of the Opioid RAND Information and Resources Research Center and the Ridge Drug Research Center. In the most recent study, researchers at RAND and Wharton School at the University of Pennsylvania examined the rate of hepatitis C infection in each state between 2004 and 2015 and studied the differences between states depending on the degree of drug use prior to reformulation. Although drug policies continue to restrict access to prescribed opiates, researchers argue that the study suggests that there may be other unwanted public health consequences if drug users inject drugs. Although hepatitis C infection rates increased nationally in the years following the reformulation, researchers found that states increased with OxyContin abuse rates above average before reformulation three times faster than other states. “These findings show that efforts to prevent opiate abuse can have undesirable and lasting consequences for public health,” said David Powell, lead author of the study and chief economist of RAND, a non-profit research organization. 22, 2018 Heroin is worse than other drugs because people inject heroin much earlier because people inject heroin, which could lead to an increased risk of injection-related epidemics such as hepatitis C and HIV, according to a new study.